Core Viewpoint - Charoen Pokphand International (03839) experienced a decline of over 7%, currently trading at HKD 7.62, with a transaction volume of HKD 5.42 million [1] Financial Performance - For the nine months ending September 30, 2025, the company expects to report an unaudited net profit attributable to shareholders of approximately USD 23.5 million, a significant increase from USD 4.3 million in the same period last year, representing a year-on-year growth of 447% [1] - The profit growth is primarily attributed to a substantial increase in revenue, reflecting the successful implementation of key strategies in developing major customer sales [1] Market Conditions - The demand for the company's veterinary pharmaceutical products is expected to decrease due to a slowdown in China's livestock industry, starting from the third quarter of 2025 [1] - The company anticipates that its unaudited quarterly net profit attributable to shareholders for the three months ending September 30, 2025, will drop to approximately USD 6.5 million, compared to USD 9.3 million for the three months ending June 30, 2025 [1]
港股异动 | 正大企业国际(03839)跌超7% 预计第三季度纯利将降至约650万美元